Showing 101,701 - 101,720 results of 113,108 for search '(( 12 m decrease ) OR ( 5 ((((we decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.77s Refine Results
  1. 101701

    Table_4_Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE Assessment.docx by Jian Lyu (7012055)

    Published 2020
    “…Groups treated with XST substantially decreased the National Institutes of Health Stroke Scale (NIHSS) score compared to the groups without XST (WMD = −5.31, 95% CI = −6.40 to −4.22, P < 0.001). …”
  2. 101702

    Table_3_Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE Assessment.docx by Jian Lyu (7012055)

    Published 2020
    “…Groups treated with XST substantially decreased the National Institutes of Health Stroke Scale (NIHSS) score compared to the groups without XST (WMD = −5.31, 95% CI = −6.40 to −4.22, P < 0.001). …”
  3. 101703

    Image_4_Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE Assessment.tif by Jian Lyu (7012055)

    Published 2020
    “…Groups treated with XST substantially decreased the National Institutes of Health Stroke Scale (NIHSS) score compared to the groups without XST (WMD = −5.31, 95% CI = −6.40 to −4.22, P < 0.001). …”
  4. 101704

    Table_2_Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE Assessment.docx by Jian Lyu (7012055)

    Published 2020
    “…Groups treated with XST substantially decreased the National Institutes of Health Stroke Scale (NIHSS) score compared to the groups without XST (WMD = −5.31, 95% CI = −6.40 to −4.22, P < 0.001). …”
  5. 101705

    Quantitative proteomic (iTRAQ) analysis of cyclin E1-interacting proteins in mouse organs in the absence of Cdk2. by Junko Odajima (3340398)

    Published 2016
    “…<p>(A) Relative abundance of cyclin E1-associated Cdk1, Cdk2, Cdk4, Cdk5 and p107 in the spleens of <i>Cdk2</i><sup><i>-/-</i></sup><i>/cyclin E1</i><sup><i>Ntag/Ntag</i></sup> mice, as compared to <i>Cdk2</i><sup><i>+/+</i></sup><i>/cyclin E1</i><sup><i>Ntag/Ntag</i></sup> animals, was determined by iTRAQ labeling and LC-MS. …”
  6. 101706

    Image_1_Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE Assessment.tif by Jian Lyu (7012055)

    Published 2020
    “…Groups treated with XST substantially decreased the National Institutes of Health Stroke Scale (NIHSS) score compared to the groups without XST (WMD = −5.31, 95% CI = −6.40 to −4.22, P < 0.001). …”
  7. 101707

    Table_1_Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE Assessment.docx by Jian Lyu (7012055)

    Published 2020
    “…Groups treated with XST substantially decreased the National Institutes of Health Stroke Scale (NIHSS) score compared to the groups without XST (WMD = −5.31, 95% CI = −6.40 to −4.22, P < 0.001). …”
  8. 101708

    Image_2_Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE Assessment.tif by Jian Lyu (7012055)

    Published 2020
    “…Groups treated with XST substantially decreased the National Institutes of Health Stroke Scale (NIHSS) score compared to the groups without XST (WMD = −5.31, 95% CI = −6.40 to −4.22, P < 0.001). …”
  9. 101709

    Image_3_Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE Assessment.tif by Jian Lyu (7012055)

    Published 2020
    “…Groups treated with XST substantially decreased the National Institutes of Health Stroke Scale (NIHSS) score compared to the groups without XST (WMD = −5.31, 95% CI = −6.40 to −4.22, P < 0.001). …”
  10. 101710

    DataSheet_2_Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE Assessment.docx by Jian Lyu (7012055)

    Published 2020
    “…Groups treated with XST substantially decreased the National Institutes of Health Stroke Scale (NIHSS) score compared to the groups without XST (WMD = −5.31, 95% CI = −6.40 to −4.22, P < 0.001). …”
  11. 101711

    DataSheet_1_Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE Assessment.docx by Jian Lyu (7012055)

    Published 2020
    “…Groups treated with XST substantially decreased the National Institutes of Health Stroke Scale (NIHSS) score compared to the groups without XST (WMD = −5.31, 95% CI = −6.40 to −4.22, P < 0.001). …”
  12. 101712
  13. 101713
  14. 101714
  15. 101715

    RanBP2 promotes the sumoylation and inhibits the ubiquitination of AGO1. by Qingtang Shen (200108)

    Published 2021
    “…Input lysates were immunoblotted with antibodies against FH-AGO1, V5-Ubc9, RanBP2 and α-tubulin. See <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009378#pgen.1009378.s010" target="_blank">S10A Fig</a> for the quantification of His6-SUMO2-FH-AGO1 levels. …”
  16. 101716

    Altered Vision-Related Resting-State Activity in Pituitary Adenoma Patients with Visual Damage by Haiyan Qian (706065)

    Published 2016
    “…It is worth mentioning that compared with HCs, V1 in PAs exhibited decreased or similar FC with the thalamus, whereas V2 and MT+ exhibited increased FCs with the thalamus, especially pulvinar.…”
  17. 101717

    Spastin is essential for photoreceptor morphogenesis in the mid-stage developing pupal eyes. by Geng Chen (194556)

    Published 2013
    “…<p>(A, B) Pupal eyes (45% pupal stage) with <i>spastin<sup>5.75</sup></i> null mutant clones marked by the absence of the GFP (green). …”
  18. 101718

    Table 1_Dynamics in the prevalence and clinical manifestations of acute mountain sickness of different ascent protocols during high altitudes exposure.doc by Caitong Zhao (20300385)

    Published 2024
    “…</p>Results<p>As diagnosed by the old LLS and new LLS, the incidence of AMS was 37.9 and 32.4% at 3650 m, respectively, which decreased to 35.7 and 32.4% after further ascending to 4,400 m in the fast ascent cohort; the incidence of AMS was 26.5 and 23.2% at 3650 m, which increased to 44.5 and 42.3% after further ascending to 4,400 m in the slow ascent cohort. …”
  19. 101719

    Supplementary file 1_Influence of attentional state on EEG-based motor imagery of lower limb.docx by Penghai Li (19823646)

    Published 2025
    “…Moreover, the TBR index proved to be an effective real-time metric, decreasing significantly under focused attention. Offline paired t-tests showed a significant TBR reduction [t<sub>(13)</sub> = 5.12, p = 2.4 × 10<sup>−5</sup>], and online analyses further validated second-by-second discrimination (Bonferroni-corrected p < 0.01). …”
  20. 101720

    Controlling Emission Energy, Self-Quenching, and Excimer Formation in Highly Luminescent N∧C∧N-Coordinated Platinum(II) Complexes by Sarah J. Farley (2658697)

    Published 2005
    “…A series of cyclometalated platinum(II) complexes have been prepared, [PtL<i><sup>n</sup></i><sup></sup>Cl], containing N∧C∧N-coordinating, terdentate ligands based on 1,3-dipyridylbenzene (HL<sup>1</sup>), incorporating aryl substituents at the central 5 position of the ligand. …”